# Potency-related Effects of Smoked Cannabis on Simulated Driving Performance

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-potency-driving-impairment-effects/
> **Published:** 2026-03-10T17:01:06-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:09:37-04:00
> **Clinical Summary:** Explore how cannabis potency driving impairment impacts simulated driving performance and clinical counseling for safer use and risk assessment.

---

✦ New

 CED Clinical Relevance
 #78
 Strong Clinical Relevance
 High-quality evidence with meaningful patient or clinical significance.

ResearchSafetyTHCDosingPolicy

 Why This Matters
 Clinicians need to understand that higher-potency cannabis products significantly impair driving ability, which is directly relevant when counseling patients about safe use and assessing impairment risk. This evidence supports clinical guidelines for screening patients about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) before prescribing medications that also affect cognition or motor function, and helps inform discussions about occupational safety with patients who drive professionally. The data strengthens clinicians’ ability to provide evidence-based guidance on product selection and consumption patterns that minimize harm to patients and the public.

 Clinical Summary

This study examined how cannabis potency affects driving performance in a simulated environment, finding that higher THC concentrations significantly impaired critical driving tasks including reaction time, lane positioning, and hazard perception. The research demonstrates a dose-dependent relationship between cannabis potency and driving impairment, with effects persisting beyond the period of subjective intoxication, which has important implications for clinicians counseling patients about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and driving safety. These findings support current [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) messaging that advises against driving after cannabis use and suggest that patient education should specifically address the potency of products being consumed, as modern high-potency formulations carry greater impairment risk than historical cannabis preparations. Clinicians should incorporate driving risk assessment into cannabis use discussions, particularly for patients in occupations requiring vehicle operation or those with safety-sensitive responsibilities. The practical takeaway is that clinicians should ask patients about their driving habits when recommending or discussing cannabis use, inform them that higher-potency products increase impairment severity, and counsel them to avoid driving for several hours after use regardless of subjective feeling of intoxication.

 Dr. Caplan’s Take
 “What this research confirms clinically is what I tell patients every day: the relationship between THC potency and driving impairment is real and dose-dependent, which means we need to move beyond ‘just don’t drive high’ to actually helping people understand their individual impairment threshold—something that varies based on tolerance, metabolism, and the specific cannabinoid profile they’re using.”

 Clinical Perspective

As [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) expands across jurisdictions, clinicians should be aware that recent research demonstrates dose-dependent impairment of simulated driving performance with smoked cannabis, particularly at higher potency levels—a finding with direct relevance to patient counseling about cannabis use and safety. While laboratory driving simulations have known limitations in predicting real-world outcomes, and individual variability in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/) and tolerance complicates risk assessment, the evidence supports a clear conversation with patients about impairment risks, especially those who drive or operate machinery. The increasing potency of commercially available cannabis products means that patients may unknowingly consume amounts that impair driving ability, even if they do not feel subjectively intoxicated. Clinicians should routinely ask about cannabis use patterns and driving habits, provide explicit guidance that cannabis use impairs driving similarly to alcohol, and consider documenting these counseling interactions in the medical record given the medicolegal implications

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

 [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Potency-related+effects+of+smoked+cannabis+on+simulated+driving+performance+-+Nature+%40drcaplan&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-026-43045-2)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-026-43045-2)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Potency-related+effects+of+smoked+cannabis+on+simulated+driving+performance+-+Nature+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-026-43045-2)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)
 

 Related Articles

- [Recreational drugs like cocaine, cannabis increase stroke risk: Study – NewsBytes](https://cedclinic.com/cannabis-stroke-risk-counseling/)

- [Study highlights stroke risk linked to recreational drugs, including among young users](https://cedclinic.com/cannabis-stroke-risk-young-users-study-highlights/)

- [In the Mix: 23 More Articles — March 04, 2026](https://cedclinic.com/cannabis-market-trends-2026-march-04/)

📰 Source: [https://www.nature.com/articles/s41598-026-43045-2](https://www.nature.com/articles/s41598-026-43045-2)

CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
CED Clinic Blog[Smart Cannabis Dosing](https://cedclinic.com/smart-cannabis-dosing/)
CED Clinic Blog[Cannabis Product Guide](https://cedclinic.com/cannabis-product-guide/)

Further Reading
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[CBD and Liver Enzymes](https://cedclinic.com/cbd-liver-enzyme-elevation-study-jama-2025/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[A new way to study how cannabis use impacts safe driving | EurekAlert!](https://cedclinic.com/cannabis-impaired-driving-research-safe-driving/)

Discover innovative research methods exploring the effects of cannabis use on driving safety and impairment.

[Learn More](https://cedclinic.com/cannabis-impaired-driving-research-safe-driving/)

[Co-use of Cannabis Edibles and Alcohol Increases Driving Impairment, suggests JAMA study](https://cedclinic.com/co-use-of-cannabis-edibles-and-alcohol-increases-driving-impairment-suggests-jama-study/)

Explore findings on how combining [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) with alcohol can exacerbate driving impairment risks.

[Read Study](https://cedclinic.com/co-use-of-cannabis-edibles-and-alcohol-increases-driving-impairment-suggests-jama-study/)

[Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW](https://cedclinic.com/prescribed-cannabis-driving-behaviours-clinical-insights/)

Review research on driving behaviors in patients prescribed cannabis, highlighting safety considerations.

[Explore Research](https://cedclinic.com/prescribed-cannabis-driving-behaviours-clinical-insights/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
